The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Discovery of HBW-3-10: A potent, orally active, reversible Bruton’s tyrosine kinase (BTK) inhibitor with antitumor activity in mice.
 
Ning Lee
Employment - Hyperway Pharmaceuticals
Leadership - Hyperway Pharmaceuticals
Stock and Other Ownership Interests - Hyperway Pharmaceuticals
 
Yingfu Li
Employment - Hyperway Pharmaceuticals
Leadership - Hyperway Pharmaceuticals
Stock and Other Ownership Interests - Hyperway Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Hyperway Pharmaceuticals
 
Chester Yuan
Employment - Hyperway Pharmaceuticals
Leadership - Hyperway Pharmaceuticals
Stock and Other Ownership Interests - Hyperway Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Hyperway Pharmaceuticals
 
Guanfeng Liu
Employment - Hyperway Pharmaceuticals
Leadership - Hyperway Pharmaceuticals
Stock and Other Ownership Interests - Hyperway Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Hyperway Pharmaceuticals
 
Chunchao Yue
Employment - Hyperway Pharmaceuticals
Stock and Other Ownership Interests - Hyperway Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Hyperway Pharmaceuticals